(Q44621307)

4 December 2017

Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation (English)

1 reference

4 December 2017

1 reference

Towler HM

1

1 reference

PubMed ID

2209919

4 December 2017

Whiting PH

series ordinal

2

1 reference

PubMed ID

2209919

4 December 2017

Forrester JV

series ordinal

3

1 reference

4 December 2017

1 January 1990

1 reference

4 December 2017

1 reference

4 December 2017

4 ( Pt 3)

1 reference

4 December 2017

514-520

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.1990.68

4 December 2017

0 references

cites work

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

Cyclosporin A in the treatment of severe Behçet's uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

Short term cyclosporin A treatment of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

Low dose cyclosporin A therapy in chronic posterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

Renal function and blood pressure in patients treated with cyclosporin a for uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

Treatment of intraocular inflammatory disease with cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Side effects of systemic cyclosporine in patients not undergoing transplantation

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Standardization of vitreal inflammatory activity in intermediate and posterior uveitis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Renal tubular function in cyclosporine-treated patients

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.68

7 January 2021

Identifiers

DOI

10.1038/EYE.1990.68

1 reference

4 December 2017

1 reference

PubMed ID

2209919